Abbott scores FDA approval for first-of-its kind dual glucose sensor

◆ ◆ The Wire takeaway

You can now build or pivot diabetes monitoring tools that combine glucose and ketone data, opening tighter integration and differentiation opportunities versus glucose-only devices. Abbott’s FDA success clears a regulatory path that may speed competition but also raises the bar on sensor capabilities.